Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital | Abdominal Radiology
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - ScienceDirect
Il PI-RADS in risonanza magnetica prostatica: cosa indica?
JCM | Free Full-Text | New Biopsy Techniques and Imaging Features of Transrectal Ultrasound for Targeting PI-RADS 4 and 5 Lesions
Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients - ScienceDirect
Ruolo della RM multiparametrica nel carcinoma prostatico
Outcomes of Magnetic Resonance Imaging–Ultrasound Fusion Prostate Biopsy of PI-RADS 3, 4, and 5 Lesions - Maria Gosein, Emily Pang, Silvia Chang, Peter Black, Larry Goldenberg, Alison Harris, Jason Yasenjiang, Masoud Yousefi, 2018
What is PI-RADS and why should you care? | THE "NEW" PROSTATE CANCER INFOLINK
Frontiers | New TRUS Techniques and Imaging Features of PI-RADS 4 or 5: Influence on Tumor Targeting
Fig. 11.12, [(a–d) PI-RADS 5 lesion in...]. - Diseases of the Abdomen and Pelvis 2018-2021 - NCBI Bookshelf
The Radiology Assistant : Prostate Cancer - PI-RADS v2.1
EPOS™
Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer | Scientific Reports
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
The Radiology Assistant : Prostate Cancer - PI-RADS v2.1
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports